Focus on breast cancer

被引：88

作者：

Baselga, J ^{[1
]}

Norton, L

机构：

[1] Vall dHebron Univ Hosp, Barcelona 08035, Spain

[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[3] Univ Autonoma Barcelona, Barcelona 08035, Spain

来源：

CANCER CELL | 2002年 / 1卷 / 04期

关键词：

D O I：

10.1016/S1535-6108(02)00066-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：319 / 322

页数：4

共 40 条

[1] Abe O, 1998, LANCET, V352, P930
[2] Adams J, 1999, CANCER RES, V59, P2615
[3] *AJCC, 1997, CANC STAG MAN
[4] Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
Albanell, J
Rojo, F
Averbuch, S
Feyereislova, A
Mascaro, JM
Herbst, R
LoRusso, P
Rischin, D
Sauleda, S
Gee, J
Nicholson, RI
Baselga, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 110 - 124
[5] Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin
Baselga, J
Pfister, D
Cooper, MR
Cohen, R
Burtness, B
Bos, M
D'Andrea, G
Seidman, A
Norton, L
Gunnett, K
Falcey, J
Anderson, V
Waksal, H
Mendelsohn, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 904 - 914
[6] Baselga J, 1998, CANCER RES, V58, P2825
[7] Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
Bier, H
Hoffmann, T
Hauser, U
Wink, M
Öchler, M
Kovar, A
Müser, M
Knecht, R
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (06) : 519 - 524
[8] CHEN HX, 2000, P AN M AM SOC CLIN, V19, pA692
[9] Clarke M, 1998, LANCET, V351, P1451
[10] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
Cummings, SR
Eckert, S
Krueger, KA
Grady, D
Powles, TJ
Cauley, JA
Norton, L
Nickelsen, T
Bjarnason, NH
Morrow, M
Lippman, ME
Black, D
Glusman, JE
Costa, A
Jordan, VC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23): : 2189 - 2197

← 1 2 3 4 →